Drug Costs: Nobody Does Price Gouging Better Than Big Pharma

by | Jul 25, 2022 | Politics & Corruption, Wealth Gap

Photo: Oleg Elkov, iStockphoto

Drug Costs: Nobody Does Price Gouging Better Than Big Pharma

by | Jul 25, 2022 | Politics & Corruption, Wealth Gap

Photo: Oleg Elkov, iStockphoto
Big Pharma companies have raised drug prices 1,186 times so far this year, further padding their bottom lines while intensifying the already overwhelming cost burden for patients.

The U.S. pharmaceutical industry exercised its virtually unlimited pricing power to hike costs for patients again this month as Senate Democrats made progress toward a limited deal to regulate out-of-control prescription drug prices, which are forcing millions of people to ration their medication or go without it entirely.

A new analysis released Wednesday by Patients for Affordable Drugs estimates that pharmaceutical companies in the U.S. have raised drug prices 1,186 times so far this year, further padding their bottom lines while intensifying the already overwhelming cost burden for patients.

Patients for Affordable Drugs found that between June 24 and July 5, pharmaceutical companies increased prices for 133 products. Pfizer, for instance, hiked the cost of its leukemia medication Besponsa again this month, bringing its per-vial price tag to $21,056.

“This is Pfizer’s fourth hike on the cancer drug during the Covid-19 pandemic—even as the company enjoys record-shattering profits from its vaccine,” the analysis notes.

The patient group also spotlighted Amgen’s price hikes for its autoimmune disease drug Enbrel. The California-based firm’s price increases for the medication have exceeded even the record-high U.S. inflation rate.

Amgen’s two price hikes for Enbrel this year alone are particularly brazen given that the company has faced recent congressional scrutiny over its business practices.

“Americans are struggling with record inflation and the continued challenges of a pandemic,” David Mitchell, the founder of Patients for Affordable Drugs, said in a statement. “Yet Big Pharma continues to raise drug prices with no regard for the health and financial well-being of Americans.”

Mitchell, a patient with incurable blood cancer whose drugs come with an annual list price of more than $900,000, argued that the pharmaceutical industry’s “latest price hikes demonstrate again why the Senate must stand up for the American people and pass the comprehensive drug pricing reforms in the reconciliation package.”

“These reforms are overwhelmingly supported by Republicans, Democrats, and independents alike, and the votes are there to pass the package immediately,” said Mitchell. “We must put an end to drug corporations’ unfettered ability to dictate prices at the expense of patients.”

Earlier this month, Senate Democrats unveiled 190 pages of legislative text containing their plan to require Medicare to negotiate the prices of a small subset of prescription drugs directly with pharmaceutical companies. The proposal also includes other measures to limit costs, such as a $2,000-a-year cap on out-of-pocket prescription drug payments for Medicare Part D enrollees.

But as The American Prospect‘s David Dayen noted earlier this month in a detailed look at the plan—which has predictably drawn opposition from the pharmaceutical industry—the legislation’s scope is highly restricted.

“In earlier versions of the bill, the negotiated prices would have been accessible to all insurance payers,” Dayen observed. “But in this bill, the prices are only available to Medicare recipients. Part B (for drugs given at hospitals) and Part D (the Medicare prescription drug benefit) drugs that Medicare spends high amounts on are eligible.”

“The drugs eligible for negotiation also have to be at least 7 to 11 years beyond their approval stage, meaning that there’s still an exclusivity buffer where newer drugs can charge whatever they want,” he continued. “Since no drug can get a negotiated price at launch, this is likely to lead to higher launch prices.”

Launch prices are already in the stratosphere: Research published last month showed that nearly half of all new brand-name prescription drugs launched in the U.S. in 2020 and 2021 had an initial price tag of $150,000 or more per year.

Ashley Suder, a patient in Morgantown, West Virginia who takes GSK’s Benlysta to manage her lupus, said that she’s had to spend “her entire paycheck” on her medications. That experience is all-too-common in the U.S., where patients spend far more on prescription drugs than their counterparts in other rich countries.

Accounting for the latest price hikes, Benlysta now carries a monthly price tag of $4,282.

“Without this drug, my immune system attacks my healthy tissue, resulting in painful inflammation that damages my skin, joints, blood vessels, and brain,” Suder said. “With the price increasing again, I worry about how I’ll make ends meet while still affording my drugs.”

Republished with permission from Common Dreams, by Jake Johnson

<a href="http://commondreams.org" target="_blank">Common Dreams</a>

Common Dreams

Common Dreams has been providing breaking news & views for the progressive community since 1997. They are independent, non-profit, advertising-free and 100% reader supported.

1 Comment

  1. Bobbi

    Something MUST BE DONE ABOUT DRUG PRICES. It absolutely makes me so VERY MAD that drug companies are allowed to price prescription drugs so high that the average person could not afford to get a drug that is helping them to survive. These patients get the drug, but then are unable to get other necessities that are also survival for their health and well-being. What is this country coming to? Not necessarily our country, but those who set the prices for needed medication so they can line their pockets without any regard for human life!!!! These individuals are selfish, uncaring, and grossly negligent in their regard for others. Those who care only about themselves and their wealth should all be sent to a small island in the middle of the ocean with only a small amount of food and have to figure out how to survive with what they have. Maybe then they would get the idea of “they” are not the only “ones”!!!!

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Follow Us

Related Articles

Nov 29 2022

Audits Reveal Medicare Advantage Plans Routinely Overcharge the Government and Taxpayers

Medicare Advantage, a fast-growing alternative to original Medicare, is run primarily by major insurance companies—which have been routinely overcharging Medicare by...
Nov 26 2022

Early Voting Starts Today in Georgia Despite Republican Efforts to Block It

The Georgia Supreme Court on Wednesday ruled against the Republican Party attempts to block local election officials from conducting advanced voting the Saturday after...
Nov 24 2022

Huh? Herschel Walker’s Primary Residence Is in Texas?

The question of the day, “How can Herschel Walker represent Georgians when he doesn’t claim Georgia as his primary residence?”
Nov 20 2022

Why Conservative Parents Are Trying to Take Over School Boards

Hundreds of parents hoping to “take back” public education ran for school board seats in the midterms. What’s the actual job that awaits those who win?
Nov 17 2022

How Banks and Private Equity Are Cashing In on Patients Who Can’t Pay Their Medical Bills

As Americans are overwhelmed with medical bills, patient financing is now a multibillion-dollar business—with profit margins topping 29 percent in the patient financing...
Nov 16 2022

Some “Do’s and Don’ts” of How the News Media Should Responsibly Cover Trump’s New Circus

When it comes to Trump, journalists—if they are to serve the public interest—must realize they are reporting on a politician who regularly defies democratic norms and...
Nov 12 2022

Georgia Senate Candidates Back on the Campaign Trail as Trump Factor Could Again Aid Warnock

Trump has been blamed for helping Warnock and Sen. Jon Ossoff win in 2021 when he spent the time before the January runoff telling Georgians the state’s election system...
Nov 10 2022

How Can Congressional Insurrectionists Be Removed from Office Under the 14th Amendment?

There is no question that certain sitting members or newly reelected members of Congress do not qualify for office under 14th Amendment. The real question is whose job...
Nov 07 2022

Billionaires Have Spent Almost a Billion Dollars Trying to Buy the Midterm Election Cycle

According to an analysis released last week by Americans for Tax Fairness, U.S. billionaires who have seen their wealth skyrocket during the coronavirus pandemic have...
Nov 05 2022

New Report Confirms Corporations Use Inflation as an Excuse for Price Gouging and Profiteering

Under the guise of inflation, certain corporations excessively hiked prices far beyond what their costs necessitated, further driving inflation.
Subscribe for Updates!

Subscribe for Updates!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Pin It on Pinterest

Share This